Shares of health-care companies rose as an increased appetite for risk helped the biotech sub sector.
Continue Reading Below
Shares of Mylan rallied after the Food and Drug Administration approved commercialization of a generic version of multiple-sclerosis drug Copaxone. The development weighed on shares of Copaxone maker Teva Pharmaceutical.
Rob Curran, email@example.com
(END) Dow Jones Newswires
October 04, 2017 16:56 ET (20:56 GMT)